Overview

Dose Finding Safety Study of VAL201 in Cancer Patients

Status:
Completed
Trial end date:
2020-01-27
Target enrollment:
Participant gender:
Summary
Dose finding safety study of VAL201 in cancer patients.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
ValiRx Plc